After the announcement of reevaluation results, we decided not to file an objection
Tirzepatide restored the aberrant levels of acetylcholine, A1-42, and pTau proteins, major AD hallmarks
Safety Profile and Long-Term Sustainability GLP-1 therapy carries a well-established safety profile supported by decades of clinical use in diabetes management, with the most common side effects being mild gastrointestinal symptomsnausea, constipation, or reduced appetitethat typically resolve within 2-4 weeks as the body adapts
Always check the label before using a sealed vial
Tesamorelin's modified structure gives it greater stability and more consistent pituitary binding
Moderate alcohol consumption is generally safe, but excessive drinking can increase the risk of low blood sugar (hypoglycaemia) and worsen nausea